Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

EXACT Sciences Corporation

EXAS
Current price
67.03 USD +3.23 USD (+5.06%)
Last closed 64 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 11 934 290 944 USD
Yield for 12 month +44.59 %
Week
Month
Year
EXAS
21.11.2021 - 28.11.2021

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719

Analytics

WallStreet Target Price

92.69 USD

P/E ratio

Dividend Yield

2.09 %

Current Year

+2 084 279 000 USD

Last Year

+1 767 087 000 USD

Current Quarter

+628 338 000 USD

Last Quarter

+622 093 000 USD

Current Year

+1 509 885 000 USD

Last Year

+1 308 330 000 USD

Current Quarter

+459 812 000 USD

Last Quarter

+465 102 000 USD

Key Figures EXAS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -144 159 008 USD
Operating Margin TTM -10.37 %
PE Ratio
Return On Assets TTM -3.4 %
PEG Ratio -1.07
Return On Equity TTM -9.06 %
Wall Street Target Price 92.69 USD
Revenue TTM 2 405 875 968 USD
Book Value 17.26 USD
Revenue Per Share TTM 13.42 USD
Dividend Share
Quarterly Revenue Growth YOY 20.1 %
Dividend Yield 2.09 %
Gross Profit TTM 1 509 885 000 USD
Earnings Share -1.58 USD
Diluted Eps TTM -1.58 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -11.73 %

Dividend Analytics EXAS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EXAS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 2.09 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EXAS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.9219
Price Sales TTM 3.9532
Enterprise Value EBITDA -18.9372
Price Book MRQ 2.603

Financials EXAS

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators EXAS

For 52 weeks

40.73 USD 100.77 USD
50 Day MA 65.44 USD
Shares Short Prior Month 8 169 512
200 Day MA 75.02 USD
Short Ratio 5.23
Shares Short 7 567 060
Short Percent 4.22 %